Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoclonal antibodies.

R Ackermann1

  • 1Department of Urology, University of Düsseldfor, West Germany.

Human Cell
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Hybridoma technology enables the routine production of specific monoclonal antibodies for diagnostics and therapeutics. Ongoing research focuses on developing novel antibodies for in vitro tumor diagnosis and in vivo applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2013
Same author

Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites.

Journal of neuro-oncology·2009
Same author

Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays.

Journal of cancer research and clinical oncology·2008
Same author

Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.

Journal of surgical oncology·2006
Same author

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.

Oncogene·2006
Same author

The necessity of functional proteomics: protein species and molecular function elucidation exemplified by in vivo alpha A crystallin N-terminal truncation.

Amino acids·2006
Same journal

Bone marrow mesenchymal stem cell-derived exosomes exert therapeutic effects on inflammatory bowel disease through miR-148a-3p/Ets-1-dependent inhibition of pyroptosis.

Human cell·2026
Same journal

A model of Helicobacter infection using an artificial liver constructed by a radial-flow bioreactor.

Human cell·2026
Same journal

CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway.

Human cell·2026
Same journal

The dynamic evolution of circulating tumor cells during glecirasib treatment predicts survival and resistance in gastrointestinal tumors with KRAS<sup>G12C</sup> mutation.

Human cell·2026
Same journal

TRERNA1-mediated acetylation represses ferroptosis of non-small cell lung cancer cells via the KAT6A/H3K23ac/TRIM24-PIK3CA pathway.

Human cell·2026
Same journal

When fatty liver fuels kidney cancer: the THRB connection.

Human cell·2026
See all related articles

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Hybridoma technology, pioneered by Köhler and Milstein, revolutionized biological sciences.
  • Monoclonal antibodies (mAbs) are now routinely produced for predefined specificity and consistent quality.
  • mAbs are crucial in diagnostics, including HLA-typing, lymphocyte differentiation, and tumor marker determination.

Purpose of the Study:

  • To highlight the significance of monoclonal antibodies in modern immunoassays and diagnostics.
  • To review the current applications and limited experience of in vivo monoclonal antibody use in malignant diseases.
  • To discuss ongoing research in producing novel murine and human monoclonal antibodies for tumor diagnosis and therapy.

Main Methods:

  • Utilizing hybridoma technology for antibody production.

Related Experiment Videos

  • Employing monoclonal antibodies in various immunoassays.
  • Investigating radiolabeled antibody immunodetection for tumor metastasis detection.
  • Exploring therapeutic applications of monoclonal antibodies in hemopoietic malignancies.

    • Main Results:

    • Monoclonal antibodies are essential for accurate tumor marker determination in immunoassays.
    • Radiolabeled antibody immunodetection shows promise for detecting metastases in colorectal and testicular cancers.
    • Therapeutic applications of monoclonal antibodies have been reported for hemopoietic system tumors.

    Conclusions:

    • Monoclonal antibodies are indispensable tools in contemporary biological and medical research.
    • Further development of monoclonal antibodies is crucial for advancing in vitro tumor diagnosis and in vivo therapeutic strategies.
    • Continued research aims to enhance the utility of monoclonal antibodies in oncology.